CureVac’s COVID-19 Vaccine Candidate, CVnCoV, Demonstrated Efficient Protection of Non-Human Primates During SARS-CoV-2 Challenge Infection
Data provided further evidence on immunogenicity and protective efficacy of CVnCoV ∙ Induction of robust…
Data provided further evidence on immunogenicity and protective efficacy of CVnCoV ∙ Induction of robust…
Guru Nanda, a Buena Park-based manufacturer of premium farm-to-home aromatherapy and other health and wellness…
Highly coveted amenities at this luxury hotel include optimal air quality (El Paso, TX) August…
Challenging times call for innovative technology solutions. The COVID-19 pandemic has increased the demand for UV-C…
NordVPN expert shares his views on COVID-19 related digital monitoring By Daniel Markuson, digital privacy…
DATELINE: AVON, M The response to the COVID-19 crisis has led to a number of…
Rapid in vitro testing of repurposed drug candidates identified by Pharnext’s PLEOTHERAPYTM Artificial Intelligence platform PARIS,…
By Rajesh Midha, Chief Strategy & Operating Officer and Healthcare Practice Lead at Bottle Rocket…
SALT LAKE CITY, APRIL 20, 2020 – In what could be an absolute game-changer in…
ABI Research whitepaper identifies the short-and long-term impacts the global pandemic will have on the…